Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1985 4
1986 1
1988 3
1989 3
1990 4
1991 8
1992 6
1993 3
1994 11
1995 8
1996 7
1997 2
1998 2
2000 7
2001 5
2002 8
2003 8
2004 10
2005 17
2006 2
2007 9
2008 3
2009 6
2010 8
2011 5
2012 4
2013 6
2014 15
2015 16
2016 13
2017 8
2018 5
2019 7
2020 6
2021 6
2022 3
2023 1
2024 2
2025 1

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

220 results

Results by year

Filters applied: . Clear all
Page 1
AUTHOR REPLY.
Kern SQ, Speir RW, Tong Y, Kaimakliotis H, Masterson TA, Bihrle R, Foster R, Koch MO, Cary C. Kern SQ, et al. Among authors: koch mo. Urology. 2021 Jun;152:189. doi: 10.1016/j.urology.2020.12.040. Urology. 2021. PMID: 34112344 No abstract available.
Editorial comment.
Koch MO. Koch MO. Urology. 2015 Feb;85(2):392-3. doi: 10.1016/j.urology.2014.08.061. Urology. 2015. PMID: 25623698 No abstract available.
Editorial comment.
Koch MO. Koch MO. Urology. 2014 Nov;84(5):1162. doi: 10.1016/j.urology.2014.06.055. Epub 2014 Oct 24. Urology. 2014. PMID: 25443921 No abstract available.
Bulimia: dentomedical complications.
Ruff JC, Koch MO, Perkins S. Ruff JC, et al. Among authors: koch mo. Gen Dent. 1992 Jan-Feb;40(1):22-5. Gen Dent. 1992. PMID: 1628792 Review. No abstract available.
Dyslipidemia, statins and prostate cancer.
Rice KR, Koch MO, Cheng L, Masterson TA. Rice KR, et al. Among authors: koch mo. Expert Rev Anticancer Ther. 2012 Jul;12(7):981-90. doi: 10.1586/era.12.75. Expert Rev Anticancer Ther. 2012. PMID: 22845413 Review.
Comparing Magnetic Resonance Imaging and Prostate-Specific Membrane Antigen-Positron Emission Tomography for Prediction of Extraprostatic Extension of Prostate Cancer and Surgical Guidance: A Prospective Nonrandomized Clinical Trial.
Bahler CD, Tachibana I, Tann M, Collins K, Swensson JK, Green MA, Mathias CJ, Tong Y, Yong C, Boris RS, Brocken E, Hutchins GD, Sims JB, Hill DV, Smith N, Ferari C, Love H, Koch MO. Bahler CD, et al. Among authors: koch mo. J Urol. 2024 Aug;212(2):290-298. doi: 10.1097/JU.0000000000004032. Epub 2024 May 24. J Urol. 2024. PMID: 38785259 Clinical Trial.
The origins of urothelial carcinoma.
Cheng L, Davidson DD, Maclennan GT, Williamson SR, Zhang S, Koch MO, Montironi R, Lopez-Beltran A. Cheng L, et al. Among authors: koch mo. Expert Rev Anticancer Ther. 2010 Jun;10(6):865-80. doi: 10.1586/era.10.73. Expert Rev Anticancer Ther. 2010. PMID: 20553211 Review.
Molecular foundations for personalized therapy in prostate cancer.
Fisher KW, Montironi R, Lopez Beltran A, Moch H, Wang L, Scarpelli M, Williamson SR, Koch MO, Cheng L. Fisher KW, et al. Among authors: koch mo. Curr Drug Targets. 2015;16(2):103-14. doi: 10.2174/1389450115666141229154500. Curr Drug Targets. 2015. PMID: 25547910 Review.
220 results